Rahi Systems Launches Cloud Strategy Headed by New CTO Matt Robinson
8.1.2020 19:00:00 EET | Business Wire | Press release
Rahi Systems announced today the launch of its cloud strategy and the addition of Matt Robinson as CTO for cloud and infrastructure. Robinson will lead the development of Rahi’s cloud services, which will leverage Rahi’s proven ability to deliver cost-effective and efficient data center infrastructure.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200108005141/en/
Cloud practices, professional services, and managed services will complement Rahi’s industry-leading expertise in data center infrastructure. (Graphic: Business Wire)
Today, every enterprise uses cloud services but few rely on the cloud exclusively. Many organizations need help developing a holistic approach across cloud and on-premises environments. The Rahi team can serve as that overlay, helping to align an organization’s cloud strategy with its data center strategy and implement the right mix of cloud services to meet business and IT requirements. Rahi also offers cloud managed services that fill skills gaps, ensure operational efficiency and optimize the cloud environment.
“Few IT solution providers offer cloud services, and most cloud companies must partner with VARs for on-premises solutions. Rahi can do both well,” said Tarun Raisoni, CEO & Co-Founder, Rahi Systems. “We are very excited to put a framework and methodology around our cloud strategy, and to have an industry veteran of Matt’s caliber heading up our cloud services.”
Robinson has been in the technology industry for the past 27 years, most recently as head of partner engineering at Google Cloud. He has previously held leadership roles at NetApp, Silicon Graphics and Alacritech across a variety of functions, including engineering, marketing, product management, professional services and customer support. “I’m delighted to be joining the Rahi family to help build a world-class cloud and infrastructure organization,” said Robinson. “Rahi’s longstanding data center and infrastructure experience at Fortune 500 clients helps set the stage for us to deliver hybrid and multi-cloud solutions across every industry vertical. With a strong focus on building a data strategy through strategic workload placement and strong governance models in cloud environments, Rahi will help its customers achieve their business goals faster and with more confidence.”
Learn more about Rahi’s cloud approach, methodology and service offerings by visiting Rahi Cloud Services.
About Rahi Systems
Rahi Systems delivers a suite of solutions and services that optimizes cost, performance, scalability, manageability and efficiency of today’s integrated environments. Founded in 2012 by entrepreneurs with deep understanding of the needs and challenges of service providers, government agencies and enterprises, the company has grown through a solutions-oriented approach, outstanding support and a culture of customer success. Rahi has its corporate headquarters in Fremont, Calif., with offices in the U.S., India, Hong Kong, Singapore, China, Taiwan, Turkey, Ireland, France, Germany, the Netherlands, the United Kingdom, Japan, South Korea, Malaysia, the Philippines, Indonesia, and Australia.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200108005141/en/
Contact information
Alison Lolis
VP of Marketing
+1 510.651.2205
alison@rahisystems.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Yubico Appoints Poupak Modirassari Enbom as Chief Marketing Officer to Accelerate Global Momentum and Drive Market Leadership30.3.2026 16:00:00 EEST | Press release
Yubico (NASDAQ STOCKHOLM: YUBICO), the creator of the most secure passkeys and a leading provider of hardware authentication security keys, today announced the appointment of Poupak Enbom as Chief Marketing Officer (CMO). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330278027/en/ Enbom joins Yubico at a pivotal moment as organizations worldwide accelerate the shift to phishing-resistant authentication and modern identity security in the age of AI. “We’re excited to welcome Poupak to Yubico,” said Jerrod Chong, acting chief executive officer, Yubico. “As the threat landscape evolves with AI-driven attacks and increasing automation, organizations are rethinking how they secure digital identities of both humans and AI agents at scale. She brings a unique combination of technical depth, global leadership, and customer-first mindset that will help us continue to expand our impact and support our customers and partners around
HistoSonics Treats First Patients Evaluating the Edison® Histotripsy System for the Treatment of Benign Prostatic Hyperplasia (BPH)30.3.2026 15:00:00 EEST | Press release
HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced the successful treatments of the first patients in WOLVERINE, a prospective feasibility trial evaluating the Edison® Histotripsy System for the treatment of benign prostatic hyperplasia (BPH) at Prince of Wales Hospital in Hong Kong, a teaching hospital for The Chinese University of Hong Kong. The Edison System is a novel, non-invasive, image guided platform that uses the mechanical properties of focused ultrasound, called histotripsy, to destroy unwanted tissue without the need for invasive procedures, and with potentially fewer side effects than traditional, invasive therapies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330349844/en/ HistoSonics Non-Invasive Edison Histotripsy System. Image credit: HistoSonics WOLVERINE is a prospective, multi-center, single-arm feasibility trial designed to evaluate
Westinghouse Celebrates Record-breaking 80 Years of Nuclear Fuel Manufacture at Springfields30.3.2026 15:00:00 EEST | Press release
The Westinghouse Springfields facility in Lancashire, UK, has marked a significant milestone as the oldest continuous nuclear fuel manufacturing site in the world, starting from its original license on the 28th, March 1946. The site was chosen by the UK Government to develop nuclear fuel for the world’s earliest civil nuclear power stations, as well as subsequent Magnox and Advanced Gas Reactors (AGR) reactors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330135973/en/ From left to right: Sophie Lemaire; Marc Chevrel; Rory O'Neill; Craig Boothby; and Robert Gofton, CEO at Nuclear Institute Across the last eight decades, the Springfields site has supported the UK nuclear fleet, manufacturing more than eight million AGR pins, sintering and pressing over 500 million AGR uranium pellets and 222,000 AGR grids – which is equivalent to burning over 685 tonnes of coal, avoiding the emission of nearly 3 billion tonnes of CO2. Sp
Biocytogen Grants Taisho Pharmaceutical a License to its RenNano ® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 14:00:00 EEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro
Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 14:00:00 EEST | Press release
Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom